Cayuga Cancer Center

Ithaca, New York 14850

3 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors Cancer, Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic, MF, MSI-H Cancer, Myelofibrosis, Non-Hodgkin Lymphoma, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis

Studies at this site

• A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now
• A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. — Recruiting now
• A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib — Recruiting now
• A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now